© 2022 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
November 16, 2020
For many years, employers, payers, and pharmacy benefit managers have been developing benefit designs to incentivize patients and providers to make cost-effective treatment decisions.
September 27, 2020
Maximizer programs are likely to lead to the dwindling or death of PAPs as we know them.
August 09, 2020
Pharmacists should be vocal in objecting to unproven therapies for COVID-19 being widely used primarily based on wishful thinking.
May 31, 2020
Consider these 5 takeaways from a pharmacy leader in an academic health care system during the COVID-19 crisis.
January 19, 2020
A more reasonable way to address shortages: price drugs at a level that provides incentive to ensure a consistent, high-quality supply.
November 18, 2019
Health System Pharmacists Should Think About the Implications of Acquiring and Dispensing These Compounded Products.